跳至主要内容
临床试验/NCT00497289
NCT00497289已完成2 期

Double-blind, Prospective, Randomized Comparison of a Medium Chain Triglycerides (MCT)/Long Chain Triglycerides (LCT)/Fish Oil (FO) Containing 20% Lipid Emulsion With a MCT/LCT Emulsion (20%) for Parenteral Nutrition in Preterm Infants

B. Braun Melsungen AG2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2006年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
48
试验地点
2
主要终点
Safety: Alanine Transaminase (ALT)

研究概览

简要总结

The study shall provide evidence for the save and efficient use of a fish oil containing lipid emulsion in parenteral nutrition of preterm infants.Safety will be assessed by monitoring hepatological and hematological laboratory parameters. Efficiency will be assessed by monitoring of inflammatory parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
5 Hours 至 3 Days(Child)
性别
All
接受健康志愿者

入选标准

  • prematurity (birth weight 500 - 1500 g)
  • postnatal age <= 72 h
  • need for cumulative parenteral energy supply of at least 70% during study duration
  • signed informed consent form

排除标准

  • simultaneous participation in another clinical study
  • platelet count below 50000 /ml
  • cumulative enteral energy supply of > 30 % during study duration
  • serious congenital infections and/or diseases
  • serious metabolic disturbances
  • severe cranial bleeding (Papile III, IV)
  • need for administration of blood products
  • contra-indication for iv lipid administration
  • withdrawal of consent

研究组 & 干预措施

1

Experimental

Lipidem 20 %

干预措施: Lipidem 20% (Drug)

2

Active Comparator

Lipofundin MCT/LCT 20%

干预措施: Lipofundin MCT/LCT 20 % (Drug)

结局指标

主要结局

Safety: Alanine Transaminase (ALT)

时间窗: on Study day -1 & 6

Change in ALT between pre/post treatment

Efficacy: Interleukin-6 (IL-6)

时间窗: on Study day -1 & 6

Change of IL-6 Measurement pre/post treatment

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Comparison of Two Different Lipid Emulsions for... | 临床试验